Biotech · Private company · Houston, TX, US

Kiromic Biopharma, Inc.

SEC CIK 0001792581

Track this companyFree. Adds Kiromic Biopharma, Inc. to your Dealase workspace and tells you when its record changes.

Clinical trials31 recruiting or active

Pipeline programs5From trials and the company's site

Disclosed deals0None found yet

Cash runwayNot availablePrivate: no SEC financials

Pipeline5

Cyclophosphamide PillPhase 2 · Progressive Solid MalignanciesClinicalTrials.gov · fetched Nov 12, 2026
Imiquimod Topical CreamPhase 2 · Progressive Solid MalignanciesClinicalTrials.gov · fetched Nov 12, 2026
TAPA-pulsed DC vaccinePhase 2 · CancerClinicalTrials.gov · fetched Nov 12, 2026
TAPA-pulsed DC vaccinePhase 2 · Progressive Solid MalignanciesClinicalTrials.gov · fetched Nov 12, 2026
KB-GDT-01Phase 1 · Carcinoma, Non-Small-Cell Lung CancerClinicalTrials.gov · fetched Nov 12, 2026

Safety Study for a Gamma Delta T Cell Product Used With Low Dose Radiotherapy in Patients With Locally Advanced or Metastatic NSCLC or Solid Tumors With Bone MetastasesPHASE1 · RECRUITING · started Nov 7, 2023ClinicalTrials.gov NCT06069570 · fetched Nov 12, 2026
Cyclophosphamide, TAPA-Pulsed Dendritic Cell Therapy and Imiquimod in Progressive and/or Refractory Solid MalignanciesPHASE1_PHASE2 · TERMINATED · started Jul 28, 2017ClinicalTrials.gov NCT02224599 · fetched Nov 12, 2026
Consolidation Therapy in Patients With Hematologic MalignanciesPHASE1_PHASE2 · WITHDRAWN · started Jul 28, 2017ClinicalTrials.gov NCT02709993 · fetched Nov 12, 2026